US2016251340A1PendingUtilityA1
Hydantoin derivatives useful as kv3 inhibitors
Est. expiryDec 6, 2030(~4.4 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 25/24A61P 25/18A61P 25/08A61P 25/28A61P 25/20A61P 27/16A61P 25/00A61K 31/4439C07D 405/14C07D 413/14C07D 307/79C07D 317/46C07D 405/12A61K 31/506C07D 413/12C07D 307/94A61K 31/4178
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A compound selected from:
spiro[1-benzofuran-3,1′-cyclopropan]-4-ol
7-methylspiro[2H-benzofuran-3,1′-cyclopropane]-4-ol
and
3,3,7-trimethyl-2,3-dihydro-1-benzofuran-4-ol
or a salt thereof; or
a compound selected from:
wherein:
X is C or N;
Y is C or N; and
the group W is selected from:
or a salt thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.